Table 4 Adverse events comparison between intervention groups at visit 5 (8 weeks)
Placebo (26) | Wenglitong (52) | Tolterodine (52) | Combination (52) | P | |||
|---|---|---|---|---|---|---|---|
W vs T | W vs C | T vsC | |||||
Dry mouth | 1 | 1 | 12 | 11 | 0.002 | 0.004 | 0.808 |
Weak stream | 0 | 0 | 9 | 3 | 0.002 | 0.243 | 0.065 |
Diarrhea | 0 | 5 | 0 | 3 | 0.024 | 0.468 | 0.241 |
Constipation | 0 | 1 | 7 | 2 | 0.057 | 0.617 | 0.085 |
Stomach discomfort | 2 | 4 | 3 | 7 | 0.709 | 0.525 | 0.314 |
Clavien system | |||||||
Grade 1 | 3 | 10 | 29 | 25 | <0.001 | 0.003 | 0.229 |
Grade 2 | 0 | 1 | 2 | 1 | 0.586 | 0.944 | 0.529 |
Grade 3/4 | 0 | 0 | 0 | 0 | -- | -- | -- |